These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 31322840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of Azacitidine and Decitabine in Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Network Meta-analysis.
    Liu W, Zhou Z, Chen L, Wang X.
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e530-e544. PubMed ID: 33716056
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical Efficacy of Decitabine-Based Chemotherapy Regimens in the Treatment of Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia].
    Li GH, Chen RA, Ji YR, Qin WW, Chen Y, Wang WQ, Liu C, Zhou NC, Liu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):743-749. PubMed ID: 29950214
    [Abstract] [Full Text] [Related]

  • 7. Decitabine: An effective and safe treatment for myelodysplastic syndrome and acute myeloid leukemia.
    Feng X, Chen X, Nie S, Chang Y, Meng F, Zhou J, Mao C, Li T, Yan X, Huang J, Liu S, Gao Y, Xiao S.
    J Cancer Res Ther; 2019 Jun; 15(7):1471-1476. PubMed ID: 31939424
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outcomes of newly diagnosed acute myeloid leukemia with myelodysplasia related changes and elderly acute myeloid leukemia following decitabine therapy in combination with priming regimen.
    Lai B, Mu Q, Zhang Y, Chen Y, Yan X, Ouyang G.
    Hematology; 2021 Dec; 26(1):751-757. PubMed ID: 34555298
    [Abstract] [Full Text] [Related]

  • 10. Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome.
    Lee ST, Jang JH, Suh HC, Hahn JS, Ko YW, Min YH.
    Am J Hematol; 2001 Dec; 68(4):237-45. PubMed ID: 11754412
    [Abstract] [Full Text] [Related]

  • 11. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG).
    de Witte T, Suciu S, Peetermans M, Fenaux P, Strijckmans P, Hayat M, Jaksic B, Selleslag D, Zittoun R, Dardenne M.
    Leukemia; 1995 Nov; 9(11):1805-11. PubMed ID: 7475266
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience.
    Filì C, Candoni A, Zannier ME, Olivieri J, Imbergamo S, Caizzi M, Nadali G, Di Bona E, Ermacora A, Gottardi M, Facchinelli D, Ciancia R, Lazzarotto D, Dubbini MV, Festini G, Gherlinzoni F, Michieli MG, Semenzato G, Fanin R.
    Leuk Res; 2019 Jan; 76():33-38. PubMed ID: 30529681
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].
    Zhang CX, Qiu SW, Gong BF, Gong XY, Li Y, Liu YT, Fang QY, Zhang GJ, Liu KQ, Zhou CL, Wei SN, Lin D, Liu BC, Wang Y, Mi YC, Wei H, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2022 May 14; 43(5):383-387. PubMed ID: 35680595
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical Efficacy and Survival Analysis of Adult Patients with Acute Myeloid Leukemia after Microtransplantation].
    Huang YJ, Zhang JH, Dong CX, Kang JM, Hou YF, Zhang YF, Qi K, Yang LH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct 14; 30(5):1361-1368. PubMed ID: 36208236
    [Abstract] [Full Text] [Related]

  • 19. [CLAG±DAC regimen in the treatment of refractory/relapsed acute myeloid leukemia].
    Hua WX, Yao WQ, Zhou M, Qi JQ, Kang HZ, Wang RJ, Cai CS, Liu YJ, Wu DP, Han Y.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Sep 14; 45(9):838-843. PubMed ID: 39414607
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.